Tirzepatide 5mg/vial, Norvo Pharmaceuticals Co., EU

Tirzepatide: A Medication for Type 2 Diabetes and Weight Loss

Tirzepatide is a medication primarily used to manage type 2 diabetes and, more recently, to aid in weight loss. It’s a relatively new injectable drug, marketed under the brand name Mounjaro.

Tirzepatide works by mimicking two natural hormones in the body: GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory peptide). Both of these hormones help regulate blood sugar levels, appetite, and food intake. Here’s how it works:

• Improves Insulin Secretion: It increases insulin release from the pancreas in response to meals, which helps lower blood sugar.
• Reduces Glucagon: It lowers the amount of glucagon (a hormone that increases blood sugar) released by the liver, helping to reduce excess glucose production.
• Delays Gastric Emptying: It slows down how quickly food leaves the stomach, helping people feel fuller for longer, which can contribute to weight loss.
• Appetite Regulation: It impacts areas of the brain involved in hunger, reducing overall food intake.

Tirzepatide has shown promising results in clinical trials, with patients experiencing significant reductions in A1c (a measure of long-term blood sugar control) and substantial weight loss. It’s usually given as a subcutaneous injection once a week.